Status:
TERMINATED
Correlation of Renal Mass Pathologic Grade and Contrast Enhanced Ultrasound (CEUS)
Lead Sponsor:
Indiana University
Conditions:
Renal Malignant Tumor
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Patients with renal lesions suspicious for renal cell carcinoma (RCC) have a variety of different treatment pathways available to them. Imaging surveillance is being used frequently on smaller renal m...
Detailed Description
Renal malignancies are relatively common, with lifetime risk ranging from 1 in 48 in men to 1 in 83 in women, of which RCC is the most common. RCC comes in a variety of subtypes, and pathologic grade ...
Eligibility Criteria
Inclusion
- Greater than or equal to 18 years of age
- Previously identified renal mass with radiology and clinical features consistent with RCC
- Clinical care plan includes partial or total nephrectomy
Exclusion
- Less than 18 years of age
- Currently pregnant
- Renal mass with clinical care plan that does not include nephrectomy
- Renal mass suspected to be non RCC neoplasm by imaging and clinical data
- Renal mass unable to be visualized by grayscale ultrasound
- Known renal vein thrombosis
Key Trial Info
Start Date :
July 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 21 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03821376
Start Date
July 16 2019
End Date
September 21 2021
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University Hospital
Indianapolis, Indiana, United States, 46022